Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.

Chow, Clara K; Ramasundarahettige, Chinthanie; Hu, Weihong; AlHabib, Khalid F; Avezum, Alvaro; Cheng, Xiaoru; Chifamba, Jephat; Dagenais, Gilles; Dans, Antonio; Egbujie, Bonaventure A; +31 more... Gupta, Rajeev; Iqbal, Romaina; Ismail, Noorhassim; Keskinler, Mirac V; Khatib, Rasha; Kruger, Lanthé; Kumar, Rajesh; Lanas, Fernando; Lear, Scott; Lopez-Jaramillo, Patricio; McKee, Martin; Mohammadifard, Noushin; Mohan, Viswanathan; Mony, Prem; Orlandini, Andres; Rosengren, Annika; Vijayakumar, Krishnapillai; Wei, Li; Yeates, Karen; Yusoff, Khalid; Yusuf, Rita; Yusufali, Afzalhussein; Zatonska, Katarzyna; Zhou, Yihong; Islam, Shariful; Corsi, Daniel; Rangarajan, Sumathy; Teo, Koon; Gerstein, Hertzel C; Yusuf, Salim; PURE investigators; (2018) Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. The lancet Diabetes & endocrinology, 6 (10). pp. 798-808. ISSN 2213-8587 DOI: https://doi.org/10.1016/S2213-8587(18)30233-X

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2213-8587(18)30233-X

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar